At Checkmate Pharmaceuticals, we believe that every person living with cancer should have the best odds for better outcomes.
Our goal is to enable more people with cancer to benefit from the promise of immunotherapies. Based on extensive experience in pharmaceutical and biologic discovery and our work with Toll-like receptor (TLR) therapies, we are leveraging our proprietary technology to harness the power of the immune system to combat cancer.
Checkmate Pharmaceuticals is a team of scientists, physicians and life sciences entrepreneurs dedicated to discovering and developing new approaches to fighting cancer. Together, we’re striving to checkmate cancer.